{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T07:37:03Z","timestamp":1773387423809,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-022-02440-0","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T16:03:00Z","timestamp":1658505780000},"page":"431-440","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Outcomes of patients with acute Vogt\u2013Koyanagi\u2013Harada disease treated with intravenous corticosteroid pulse followed by the slow tapering of oral corticosteroid therapy"],"prefix":"10.1007","volume":"43","author":[{"given":"Rui","family":"Fushitsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Ishibazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Murono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1344-1641","authenticated-orcid":false,"given":"Reiko","family":"Kinouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"2440_CR1","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s002510050375","volume":"47","author":"H Kobayashi","year":"1998","unstructured":"Kobayashi H, Kokubo T, Takahashi M, Sato K, Miyokawa N, Kimura S, Kinouchi R, Katagiri M (1998) Tyrosinase epitope recognized by an HLA-DR-restricted T-cell line from a Vogt-Koyanagi-Harada disease patient. Immunogenetics 47:398\u2013403. https:\/\/doi.org\/10.1007\/s002510050375","journal-title":"Immunogenetics"},{"key":"2440_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.survophthal.2016.05.002","volume":"62","author":"GA O'Keefe","year":"2017","unstructured":"O\u2019Keefe GA, Rao NA (2017) Vogt-Koyanagi-Harada disease. Surv Ophthalmol 62:1\u201325. https:\/\/doi.org\/10.1016\/j.survophthal.2016.05.002","journal-title":"Surv Ophthalmol"},{"key":"2440_CR3","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1136\/bjo.80.11.1002","volume":"80","author":"K Norose","year":"1996","unstructured":"Norose K, Yano A (1996) Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease. Br J Ophthalmol 80:1002\u20131008. https:\/\/doi.org\/10.1136\/bjo.80.11.1002","journal-title":"Br J Ophthalmol"},{"key":"2440_CR4","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.2147\/OPTH.S94866","volume":"10","author":"A Baltmr","year":"2016","unstructured":"Baltmr A, Lightman S, Tomkins-Netzer O (2016) Vogt-Koyanagi-Harada syndrome - current perspectives. Clin Ophthalmol 10:2345\u20132361. https:\/\/doi.org\/10.2147\/OPTH.S94866","journal-title":"Clin Ophthalmol"},{"key":"2440_CR5","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1001\/archopht.1991.01080050096037","volume":"109","author":"PE Rubsamen","year":"1991","unstructured":"Rubsamen PE, Gass JDM (1991) Vogt-Koyanagi-Harada syndrome: clinical course, therapy, and long-term visual outcome. Arch Ophthalmol 109:682\u2013687. https:\/\/doi.org\/10.1001\/archopht.1991.01080050096037","journal-title":"Arch Ophthalmol"},{"issue":"154\u2013161","key":"2440_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2008.07.044","volume":"147","author":"SP Chee","year":"2009","unstructured":"Chee SP, Jap A, Bacsal K (2009) Prognostic factors of Vogt-Koyanagi-Harada disease in Singapore. Am J Ophthalmol 147(154\u2013161):e151. https:\/\/doi.org\/10.1016\/j.ajo.2008.07.044","journal-title":"Am J Ophthalmol"},{"key":"2440_CR7","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s00417-008-0869-5","volume":"246","author":"N Kitaichi","year":"2008","unstructured":"Kitaichi N, Horie Y, Ohno S (2008) Prompt therapy reduces the duration of systemic corticosteroids in Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol 246:1641\u20131642. https:\/\/doi.org\/10.1007\/s00417-008-0869-5","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2440_CR8","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000310145","volume":"201","author":"Y Sasamoto","year":"1990","unstructured":"Sasamoto Y, Ohno S, Matsuda H (1990) Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease. Ophthalmologica 201:162\u2013167. https:\/\/doi.org\/10.1159\/000310145","journal-title":"Ophthalmologica"},{"key":"2440_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/eye.2008.89","volume":"23","author":"TY Lai","year":"2009","unstructured":"Lai TY, Chan RP, Chan CK, Lam DS (2009) Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease. Eye (Lond) 23:543\u2013548. https:\/\/doi.org\/10.1038\/eye.2008.89","journal-title":"Eye (Lond)"},{"key":"2440_CR10","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/s0002-9394(01)00937-0","volume":"131","author":"RW Read","year":"2001","unstructured":"Read RW, Rechodouni A, Butani N, Johnston R, LaBree LD, Smith RE, Rao NA (2001) Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 131:599\u2013606. https:\/\/doi.org\/10.1016\/s0002-9394(01)00937-0","journal-title":"Am J Ophthalmol"},{"key":"2440_CR11","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1136\/bjophthalmol-2017-311691","volume":"103","author":"M Nakayama","year":"2019","unstructured":"Nakayama M, Keino H, Watanabe T, Okada AA (2019) Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids. Br J Ophthalmol 103:274\u2013278. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311691","journal-title":"Br J Ophthalmol"},{"key":"2440_CR12","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00417-014-2904-z","volume":"253","author":"VM Sakata","year":"2015","unstructured":"Sakata VM, da Silva FT, Hirata CE, Marin ML, Rodrigues H, Kalil J, Costa RA, Yamamoto JH (2015) High rate of clinical recurrence in patients with Vogt-Koyanagi-Harada disease treated with early high-dose corticosteroids. Graefes Arch Clin Exp Ophthalmol 253:785\u2013790. https:\/\/doi.org\/10.1007\/s00417-014-2904-z","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2440_CR13","unstructured":"Russell W. Read M, Gary N. Holland, MD, Narsing A. Rao, MD,, Khalid F. Tabbara M, Shigeaki Ohno, MD, Lourdes Arellanes-Garcia, MD, Paola pivetti-pezZI, MD, Howard H. Tessler, MD, and Masahiko USUI, MD (2001) Revised Diagnostic Criteria for Vogt-Koyanagi-Harada Disease: Report of an International Committee on Nomenclature. Am J Ophthalmol"},{"key":"2440_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00774-014-0586-6","volume":"32","author":"Y Suzuki","year":"2014","unstructured":"Suzuki Y, Nawata H, Soen S, Fujiwara S, Nakayama H, Tanaka I, Ozono K, Sagawa A, Takayanagi R, Tanaka H, Miki T, Masunari N, Tanaka Y (2014) Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update. J Bone Miner Metab 32:337\u2013350. https:\/\/doi.org\/10.1007\/s00774-014-0586-6","journal-title":"J Bone Miner Metab"},{"key":"2440_CR15","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. results of the first international workshop. Am J Ophthalmol 140:509\u2013516. https:\/\/doi.org\/10.1016\/j.ajo.2005.03.057","journal-title":"Am J Ophthalmol"},{"key":"2440_CR16","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant 48:452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"key":"2440_CR17","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/s0002-9394(01)00925-4","volume":"131","author":"RW Read","year":"2001","unstructured":"Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, Pivetti-Pezzi P, Tessler HH, Usui M (2001) Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131:647\u2013652. https:\/\/doi.org\/10.1016\/s0002-9394(01)00925-4","journal-title":"Am J Ophthalmol"},{"key":"2440_CR18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ajo.2016.06.004","volume":"168","author":"E Shen","year":"2016","unstructured":"Shen E, Rathinam SR, Babu M, Kanakath A, Thundikandy R, Lee SM, Browne EN, Porco TC, Acharya NR (2016) Outcomes of Vogt-Koyanagi-Harada disease: a subanalysis from a randomized clinical trial of antimetabolite therapies. Am J Ophthalmol 168:279\u2013286. https:\/\/doi.org\/10.1016\/j.ajo.2016.06.004","journal-title":"Am J Ophthalmol"},{"key":"2440_CR19","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.ophtha.2019.03.049","volume":"126","author":"P Yang","year":"2019","unstructured":"Yang P, Liu S, Zhong Z, Du L, Ye Z, Zhou W, Kijlstra A (2019) Comparison of clinical features and visual outcome between sympathetic Ophthalmia and Vogt-Koyanagi-Harada disease in chinese patients. Ophthalmology 126:1297\u20131305. https:\/\/doi.org\/10.1016\/j.ophtha.2019.03.049","journal-title":"Ophthalmology"},{"key":"2440_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.18240\/ijo.2017.01.16","volume":"10","author":"VE Giordano","year":"2017","unstructured":"Giordano VE, Schlaen A, Guzman-Sanchez MJ, Couto C (2017) Spectrum and visual outcomes of Vogt-Koyanagi-Harada disease in Argentina. Int J Ophthalmol 10:98\u2013102. https:\/\/doi.org\/10.18240\/ijo.2017.01.16","journal-title":"Int J Ophthalmol"},{"key":"2440_CR21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3109\/09273948.2015.1025984","volume":"24","author":"JF Arevalo","year":"2016","unstructured":"Arevalo JF, Lasave AF, Gupta V, Kozak I, Al Harbi MB, Al Rushood AA, Al Dhibi HA (2016) Clinical outcomes of patients with Vogt-Koyanagi-Harada disease over 12 years at a tertiary center. Ocul Immunol Inflamm 24:521\u2013529. https:\/\/doi.org\/10.3109\/09273948.2015.1025984","journal-title":"Ocul Immunol Inflamm"},{"key":"2440_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10384-015-0377-1","volume":"59","author":"C Iwahashi","year":"2015","unstructured":"Iwahashi C, Okuno K, Hashida N, Nakai K, Ohguro N, Nishida K (2015) Incidence and clinical features of recurrent Vogt-Koyanagi-Harada disease in Japanese individuals. Jpn J Ophthalmol 59:157\u2013163. https:\/\/doi.org\/10.1007\/s10384-015-0377-1","journal-title":"Jpn J Ophthalmol"},{"key":"2440_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10792-006-9021-x","volume":"27","author":"NA Rao","year":"2007","unstructured":"Rao NA, Sukavatcharin S, Tsai JH (2007) Vogt-Koyanagi-Harada disease diagnostic criteria. Int Ophthalmol 27:195\u2013199. https:\/\/doi.org\/10.1007\/s10792-006-9021-x","journal-title":"Int Ophthalmol"},{"key":"2440_CR24","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.ajo.2005.01.046","volume":"139","author":"M Kitamura","year":"2005","unstructured":"Kitamura M, Takami K, Kitaichi N, Namba K, Kitamei H, Kotake S, Ohno S (2005) Comparative study of two sets of criteria for the diagnosis of Vogt-Koyanagi-Harada\u2019s disease. Am J Ophthalmol 139:1080\u20131085. https:\/\/doi.org\/10.1016\/j.ajo.2005.01.046","journal-title":"Am J Ophthalmol"},{"key":"2440_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/tan.12536","volume":"85","author":"N Ikeda","year":"2015","unstructured":"Ikeda N, Kojima H, Nishikawa M, Hayashi K, Futagami T, Tsujino T, Kusunoki Y, Fujii N, Suegami S, Miyazaki Y, Middleton D, Tanaka H, Saji H (2015) Determination of HLA-A, -C, -B, -DRB1 allele and haplotype frequency in Japanese population based on family study. Tissue Antigens 85:252\u2013259. https:\/\/doi.org\/10.1111\/tan.12536","journal-title":"Tissue Antigens"},{"key":"2440_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0198-8859(94)90257-7","volume":"39","author":"Y Shindo","year":"1994","unstructured":"Shindo Y, Ohno S, Yamamoto T, Nakamura S, Inoko H (1994) Complete association of the HLA-DRB1 \u221704 and -DQB1 \u221704 alleles with Vogt-Koyanagi-Harada\u2019s disease. Hum Immunol 39:169\u2013176. https:\/\/doi.org\/10.1016\/0198-8859(94)90257-7","journal-title":"Hum Immunol"},{"key":"2440_CR27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ajo.2006.02.049","volume":"142","author":"RW Read","year":"2006","unstructured":"Read RW, Yu F, Accorinti M, Bodaghi B, Chee SP, Fardeau C, Goto H, Holland GN, Kawashima H, Kojima E, Lehoang P, Lemaitre C, Okada AA, Pivetti-Pezzi P, Secchi A, See RF, Tabbara KF, Usui M, Rao NA (2006) Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease. Am J Ophthalmol 142:119\u2013124. https:\/\/doi.org\/10.1016\/j.ajo.2006.02.049","journal-title":"Am J Ophthalmol"},{"key":"2440_CR28","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s00417-017-3654-5","volume":"255","author":"UC Park","year":"2017","unstructured":"Park UC, Cho IH, Lee EK, Yu HG (2017) The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol 255:1203\u20131211. https:\/\/doi.org\/10.1007\/s00417-017-3654-5","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2440_CR29","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s10792-016-0395-0","volume":"37","author":"CP Herbort Jr","year":"2017","unstructured":"Herbort CP Jr, Abu El Asrar AM, Yamamoto JH, Pav\u00e9sio CE, Gupta V, Khairallah M, Tugal-Tutkun I, Soheilian M, Takeuchi M, Papadia M (2017) Reappraisal of the management of Vogt-Koyanagi-Harada disease: sunset glow fundus is no more a fatality. Int Ophthalmol 37:1383\u20131395. https:\/\/doi.org\/10.1007\/s10792-016-0395-0","journal-title":"Int Ophthalmol"},{"key":"2440_CR30","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/s0190-9622(08)81508-3","volume":"30","author":"KP White","year":"1994","unstructured":"White KP, Driscoll MS, Rothe MJ, Grant-Kels JM (1994) Severe adverse cardiovascular effects of pulse steroid therapy: is continuous cardiac monitoring necessary? J Am Acad Dermatol 30:768\u2013773. https:\/\/doi.org\/10.1016\/s0190-9622(08)81508-3","journal-title":"J Am Acad Dermatol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02440-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-022-02440-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02440-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T02:04:15Z","timestamp":1677549855000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-022-02440-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["2440"],"URL":"https:\/\/doi.org\/10.1007\/s10792-022-02440-0","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]},"assertion":[{"value":"23 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the institutional review board of Asahikawa Medical University (approval number: 18257).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The requirement to obtain informed consent was waived by the institutional review board of Asahikawa Medical University.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}